Ravi Yang Sarin - Mar 17, 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Ravi Yang Sarin
Stock symbol
TOI
Transactions as of
Mar 17, 2023
Transactions value $
$0
Form type
4
Date filed
3/21/2023, 08:52 PM
Previous filing
Nov 21, 2022
Next filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +29.5K +64.33% $0.00 75.4K Mar 17, 2023 Direct F1
holding TOI Common stock 4.11M Mar 17, 2023 LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date.